Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy - Related Studies

Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy

This study is currently recruiting participants.

Study NCT00666263. Last updated on December 2, 2008. Information provided by Baxter Healthcare Corporation

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Multifocal Motor Neuropathy

2	Additional conditions recognized in this trial
		Neuritis

3	More general conditions related to this trial
		Nervous System Diseases
		Neuromuscular Diseases
		Peripheral Nervous System Diseases

4	Interventions listed in this trial
		Immune Globulin Intravenous, 10%

5	Additional drug interventions recognized in this trial
		Immunoglobulins
		Immunoglobulins, Intravenous
		Rho(D) Immune Globulin

6	More general drug interventions related to this trial
		Immunologic Factors
		Pharmacologic Actions
		Physiological Effects of Drugs

7	Sponsors listed in this trial
		Baxter Healthcare Corporation